Study Evaluating the Efficacy and Safety of Three Formulations of Ultra-low Dose Estriol Vaginal Gel (0.005%, 0.002%, 0.0008% Estriol Vaginal Gel) for the Treatment of Vaginal Dryness in Postmenopausal Women With Vulvovaginal Atrophy

For additional information regarding investigative sites for this trial, contact ITF Research Pharma S.L.U., Tatabánya

For additional information regarding investigative sites for this trial, contact ITF Research Pharma S.L.U, Szeged

For additional information regarding investigative sites for this trial, contact ITF Research Pharma S.L.U., Szentes

For additional information regarding investigative sites for this trial, contact ITF Research Pharma S.L.U, Székesfehérvár

For additional information regarding investigative sites for this trial, contact ITF Research Pharma S.L.U., Pavia

For additional information regarding investigative sites for this trial, contact ITF Research Pharma S.L.U., Murcia

For additional information regarding investigative sites for this trial, contact ITF Research Pharma S.L.U., Santander

For additional information regarding investigative sites for this trial, contact ITF Research Pharma S.L.U., Modena

For additional information regarding investigative sites for this trial, contact ITF Research Pharma S.L.U., Valencia

For additional information regarding investigative sites for this trial, contact ITF Research Pharma S.L.U., Siena

For additional information regarding investigative sites for this trial, contact ITF Research Pharma S.L.U., Barcelona

For additional information regarding investigative sites for this trial, contact ITF Research Pharma S.L.U., Catanzaro

For additional information regarding investigative sites for this trial, contact ITF Research Pharma S.L.U., Catania

For additional information regarding investigative sites for this trial, contact ITF Research Pharma S.L.U, Brno

For additional information regarding investigative sites for this trial, contact ITF Research Pharma S.L.U., České Budějovice

For additional information regarding investigative sites for this trial, contact ITF Research Pharma S.L.U., Olomouc

For additional information regarding investigative sites for this trial, contact ITF Research Pharma S.L.U., Olomouc

For additional information regarding investigative sites for this trial, contact ITF Research Pharma S.L.U., Prague

For additional information regarding investigative sites for this trial, contact ITF Research Pharma S.L.U., Vsetín

For additional information regarding investigative sites for this trial, contact ITF Research Pharma S.L.U., Písek

For additional information regarding investigative sites for this trial, contact ITF Research Pharma S.L.U., Huddinge

For additional information regarding investigative sites for this trial, contact ITF Research Pharma S.L.U., Kungsbacka

For additional information regarding investigative sites for this trial, contact ITF Research Pharma S.L.U., Stockholm